Does Mounjaro help PCOS?

Quick answer

Mounjaro (tirzepatide) may improve weight and insulin-related features in some people with PCOS, but it is not a proven cure and evidence specific to PCOS is still developing. Discuss approved indications, contraception, pregnancy plans, and alternatives with a clinician; do not use it during pregnancy.

Does Mounjaro help PCOS?

Mounjaro may help some people with PCOS by supporting weight management and improving blood sugar control when they meet prescribing criteria. It is not a licensed treatment for PCOS itself. Direct evidence for improving PCOS symptoms or fertility is limited, and contraception and pregnancy planning are essential parts of care.

Why might a weight-management medicine help?

Polycystic ovary syndrome, or PCOS, can affect periods, skin, hair growth and fertility. Many people also have insulin resistance: their tissues respond less effectively to insulin, the hormone that helps control blood sugar. Higher insulin levels can contribute to increased ovarian production of androgens, hormones such as testosterone, and disrupted ovulation, the release of an egg.

Tirzepatide, sold as Mounjaro, acts on two gut-hormone pathways involved in appetite and blood sugar. Weight reduction and improved metabolic health may help some PCOS-related problems indirectly. PCOS occurs across body sizes, however, and weight loss is neither a requirement for receiving care nor a cure for the condition.

What does the evidence actually establish?

The international PCOS guideline allows consideration of weight-management medicines, including certain GLP-1 medicines, alongside supported lifestyle care for adults with higher weight, following general prescribing guidance. That is not equivalent to a recommendation that tirzepatide treats every feature of PCOS.

Trials demonstrating tirzepatide's effects on weight or diabetes do not establish a specific effect on unwanted hair, acne, ovulation or live birth in PCOS. Direct PCOS evidence remains limited. It would be misleading to promise that Mounjaro will normalise hormones or restore fertility, or to extrapolate results from another medicine without qualification.

Who might reasonably consider it?

A clinician can consider Mounjaro when the licensed weight-management or diabetes indication fits your health circumstances. PCOS alone does not automatically make someone eligible. The assessment should consider weight-related health problems, glucose tests, other medicines, eating difficulties, gastrointestinal disease and pregnancy intentions. NHS access rules are separate from the product licence.

Treatment goals should include health and wellbeing, not just the scales. Support with food, movement, sleep and distress should be practical and non-judgemental. Difficulty managing weight with PCOS is not evidence of insufficient effort.

What other PCOS treatment might still be needed?

Irregular or absent periods need attention even if weight is changing. Depending on your situation, a clinician may discuss the combined contraceptive pill, periodic progestogen to protect the womb lining, or metformin for metabolic indications. Acne, unwanted hair growth and fertility concerns can need separate treatment. A weight-management prescription should not replace this care.

Review should look at symptoms, menstrual pattern, blood pressure, glucose and tolerability, rather than assuming a smaller waist means every PCOS risk has resolved. A prolonged gap between periods deserves advice about protecting the womb lining.

What are the contraception and pregnancy precautions?

Mounjaro is not a fertility medicine and should not be used during pregnancy or while trying to conceive. Ovulation may change as metabolic health changes, so irregular periods are not reliable contraception.

If you use an oral contraceptive, switch to a non-oral method or add a barrier method for four weeks after starting Mounjaro and for four weeks after every dose increase. This precaution reflects its potential to reduce pill effectiveness. Stop tirzepatide at least one month before a planned pregnancy, with your clinician arranging alternative diabetes care if needed. If pregnancy occurs, stop it and contact your prescriber promptly. Discuss breastfeeding before treatment; do not assume safety.

When should you seek help?

Speak to your prescriber about persistent nausea, vomiting, constipation or inadequate intake before increasing the dose. Severe persistent abdominal pain, with or without vomiting and especially radiating to the back, requires stopping treatment and urgent assessment for pancreatitis. Inability to keep fluids down or markedly reduced urine also warrants urgent advice. Very heavy bleeding, severe pelvic pain or a positive pregnancy test with pain needs prompt assessment, not attribution to PCOS.

Sources & further reading

Dr Chinnadorai Rajeswaran

Reviewed by

Dr Chinnadorai Rajeswaran

Specialist Endocrinologist · MBBS MRCP FRCP

Last Reviewed: November 2026

Read about PCOS and related care.